Key result
A novel risk index (MACERI) incorporating clinical, metabolic, and angiographic factors strongly predicted one-year major cardiovascular events in patients with ACS and diabetes undergoing PCI.
Why the study?
Increased MACE risk after PCI in patients with ACS and diabetes mellitus is not sufficiently estimated multidimensionally across clinical, metabolic, and angiographic factors.
Does a multidimensional risk index (MACERI) improve the prediction of one-year MACE compared to SYNTAX and ACEF scores in patients with ACS and DM undergoing PCI?
Cross-Sectional (n=136)
Does a multidimensional risk index (MACERI) improve the prediction of one-year MACE compared to SYNTAX and ACEF scores in patients with ACS and DM undergoing PCI?
A newly developed multidimensional risk index (MACERI) provides superior prediction of one-year MACE compared to existing scores in patients with ACS and diabetes undergoing PCI.
Answers are grounded in this paper and cite their sources.
MACERI improves one-year MACE prediction over SYNTAX/ACEF in ACS-DM post-PCI; leaves open external validation before clinical use.
Background/Aim. Patients with acute coronary syndrome (ACS) and diabetes mellitus (DM) have an increased risk of major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI), which is not estimated sufficiently-multidimensionally in terms of type and severity of the ACS and/or DM and angiographic findings. The study was intended to validate and develop an index of metabolic, angiographic, anatomic and clinical risk factors for one-year MACE after conducted PCI in patients with ACS and DM. Methods. A prospective cross-sectional study was performed in patients with DM and ACS. In the PCI period the following risk factors were recorded: 1) age and metabolic variables ? glycosylated hemoglobin (HbA1c), total cholesterol, and triglycerides levels in the blood; 2) endocrinological variables ? DM therapy and type of DM; 3) ACS modality; 4) radiological/anatomical variable ? SYNTAX score, and 5) clinical variables in modified age, creatinine, ejection fraction (ACEF) score. One-year MACE were recorded. Results. From a total of 136 consecutive patients, 55 of them developed at least one MACE in one-year follow-up. A high predictive risk index was evaluated that assessed particular or associated risks for one-year MACE (c statistic = 0.879) in the study population, defined by: SYNTAX score > 21, modified ACEF score > 1.38, HbA1c ? 8%, triglyceridemia ? 2.3 mmol/L in patients with insulin therapy, and ACS modality ? unstable angina pectoris. The constructed risk index for one-year MACE (MACERI) had better predictive characteristics than SYNTAX score (c statistic = 0.798), as well as ACF score (c statistic = 0.744). Conclusion. MACERI can potentially have great application in future risk factors studies for one-year MACE in patients with DM and ACS who underwent PCI, because with it the effects of these factors are measured multidimensionally at valid and accurate manner.
No takes yet. Share an insight, caveat, or question.
Mirković et al. (2019) conducted a cross-sectional in Acute coronary syndrome and diabetes mellitus (n=136). MACERI (major adverse cardiac events risk index) was evaluated on One-year major adverse cardiovascular events (MACE) (c statistic = 0.879). A novel risk index (MACERI) incorporating clinical, metabolic, and angiographic factors strongly predicted one-year major cardiovascular events in patients with ACS and diabetes undergoing PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: